Author | Alex Delaney-Gesing


Evaluating 3-year recurrence rate on non-infectious posterior segment veitis post-FAi

August 11, 2020


Dilraj Grewal, MD, speaks on his presentation "Evaluating the True 3-Year Recurrence Rate in Non-infectious Posterior Segment Uveitis Following an Injectable Fluocinolone Acetonide Insert," during ASRS 2020.

ASRS 2020: Impact of baseline OCT on response to risuteganib for treatment of intermediate AMD

August 04, 2020


Justis P. Ehlers, MD, speaks on the key findings and take-aways from his presentation "Impact of baseline OCT characteristics on response to risuteganib for the treatment of intermediate age-related macular degeneration (AMD)."

ASRS 2020: Dexamethasone intracameral drug-delivery suspension in vitreoretinal surgery inflammation

August 03, 2020


Daniel F. Kiernan, MD, FCS, speaks on the key findings and take-aways of his presentation "Dexamethasone intracameral drug-delivery suspension for inflammation associated with vitreoretinal surgery."

ASRS 2020: How one surgeon is integrating recent retina advances in COVID-19

August 02, 2020


S.K. Steven Houston III, MD, discusses retina innovations in use in his practice, including the NGENUITY 1.4 upgrade from Alcon, and adapting to ever-changing operating room spacing and set-up in the COVID-19 environment